Nigel Walker
Contract service providers to the (bio)pharmaceutical industry must help their customers speed the development of new drugs while reducing costs.
Peter Cramer
Evolution in the life sciences industry is driving the need for new manufacturing paradigms based on advanced technologies.
Wes Wheeler, Ariette van Strien
To properly facilitate this, Supply Chain Logistics Providers must not only be experienced with all relevant customs regulations and the specialized requirements for shipping these sensitive materials, they must be adept at risk management and contingency planning to ensure that clinical trial materials are safeguarded throughout the delivery process.
Guy Tiene, MA
Nice Insight Is in Conversation With Dago Caceres, Marketing Director, and Gary Lord, Global Strategic Marketing Director at the Dow Chemical Company, to Discuss the Drivers of the merger between Dow and Dow Corning, and the positive impact the Move Will have on Dow’s Pharma customers.
Jun Yokohama, Toshio Yoshioka
Currently, the global pharmaceutical market is expanding at a robust compound annual growth rate (CAGR) of 6.3%, according to Evaluate Pharma, with global pharmaceutical R&D spending increasing annually at approximately 2.8%.
Richard O. Snyder, Ph.D., Scott Jeffers, Ying Cai
The rapid progress of cell and gene therapies through clinical development is driving demand for late-stage clinical and commercial manufacturing capabilities.
Renaud Bessière
The Russian market presents new growth opportunities for pharmaceutical companies with manufacturing capabilities within the country.
Cynthia A. Challener, Ph.D., Carrie Cao, Emilie Branch
As a global supply chain becomes the new norm, local issues have increasingly entered the dialogue
around production.
Cynthia A. Challener, Ph.D., Carrie Cao, Emilie Branch
Global CRO Market: Overview Driven by the growing number of clinical trials and demand for advanced medicines across the globe, the CRO market is projected to reach $59.42 billion by 2020 at a compound annual growth rate (CAGR) of 9.8% from 2015 to 2020, according to Zion Market Research.
Cynthia A. Challener, Ph.D., Carrie Cao, Emilie Branch
The need for greater speed across all activities in the pharmaceutical industry not only impacts discovery and development of new drug candidates, but also the design, construction and validation of new facilities, and the upgrading of existing plants.
Warren Horton
Providing customers with their order when they want it, at the right price and quantity, is only laying the foundation for excellent customer service.
Witold Lehmann
Mapping out an effective, coherent, long-term manufacturing strategy is likely one of the more difficult tasks facing any drug owner or developer. For oral solid dose (OSD) drug manufacturers, the
past 10-15 years have seen manufacturing strategies change drastically, with a focus on achieving more, with less.
Angela Moore
As the number of opioid prescriptions in the US has climbed dramatically, so has the abuse and misuse
of these drugs, leading to loss of life and significant social costs. The pharmaceutical industry, in conjunction with FDA, has focused on identifying approaches for the development of abuse-deterrent opioid formulations and methods for demonstrating their effectiveness.
Emilie Branch, Kshitij (TJ) Ladage
The research enterprise of That’s Nice — Nice Insight — has grown signifi cantly over the past seven years and now encompasses our core Nice Insight Research Services, as well as Pharma’s Almanac, which offers rich data-driven content.
The integration of the Pharma’s Almanac with Nice Insight was a clear next step, as both sites are powered by research.
Success in international markets is fundamental to the progression and growth of our pharmaceutical business. This demographic is driven by the geography of the market itself, in terms of current
global pharmaceutical consumption and predicted regional growth, as well as the regulatory requirement for regional testing to support global and local product registration.
Safely over the bridge and through the
verdant pasture land of New Jersey’s greater
Princeton area, we were greeted by Envigo’s
Joe Bedford with some sound advice
on putting early development on the right
road by meeting regulatory guidelines.
Facing a minor run-in ourselves with the
local regulatory agency shortly thereafter,
we were grateful for Bedford’s timely advice
at this early stage of our journey.